Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Conference item |
| Опубликовано: |
2005
|
| _version_ | 1826266133654667264 |
|---|---|
| author | Leask, A Xu, S Renzoni, E Bou-Gharios, G du Bois, R Abraham, D Black, C |
| author_facet | Leask, A Xu, S Renzoni, E Bou-Gharios, G du Bois, R Abraham, D Black, C |
| author_sort | Leask, A |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T20:34:19Z |
| format | Conference item |
| id | oxford-uuid:321b13b9-0a2f-4d8d-90f8-61f08b0cc7c5 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T20:34:19Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:321b13b9-0a2f-4d8d-90f8-61f08b0cc7c52022-03-26T13:11:58ZBosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:321b13b9-0a2f-4d8d-90f8-61f08b0cc7c5Symplectic Elements at Oxford2005Leask, AXu, SRenzoni, EBou-Gharios, Gdu Bois, RAbraham, DBlack, C |
| spellingShingle | Leask, A Xu, S Renzoni, E Bou-Gharios, G du Bois, R Abraham, D Black, C Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma. |
| title | Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma. |
| title_full | Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma. |
| title_fullStr | Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma. |
| title_full_unstemmed | Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma. |
| title_short | Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma. |
| title_sort | bosentan alleviates the pro fibrotic phenotype of lung scleroderma fibroblasts implications for treatment of scleroderma |
| work_keys_str_mv | AT leaska bosentanalleviatestheprofibroticphenotypeoflungsclerodermafibroblastsimplicationsfortreatmentofscleroderma AT xus bosentanalleviatestheprofibroticphenotypeoflungsclerodermafibroblastsimplicationsfortreatmentofscleroderma AT renzonie bosentanalleviatestheprofibroticphenotypeoflungsclerodermafibroblastsimplicationsfortreatmentofscleroderma AT boughariosg bosentanalleviatestheprofibroticphenotypeoflungsclerodermafibroblastsimplicationsfortreatmentofscleroderma AT duboisr bosentanalleviatestheprofibroticphenotypeoflungsclerodermafibroblastsimplicationsfortreatmentofscleroderma AT abrahamd bosentanalleviatestheprofibroticphenotypeoflungsclerodermafibroblastsimplicationsfortreatmentofscleroderma AT blackc bosentanalleviatestheprofibroticphenotypeoflungsclerodermafibroblastsimplicationsfortreatmentofscleroderma |